![Thomas Murtagh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Murtagh
Direktor/Vorstandsmitglied bei Silver Creek Pharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von Thomas Murtagh
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Silver Creek Pharmaceuticals, Inc.
![]() Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA.
5
| Private Company | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Thomas Murtagh
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
LIGHT & WONDER, INC. | Casinos/Gaming | Director/Board Member | |
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Barclays Bank Plc
![]() Barclays Bank Plc Major BanksFinance Barclays Bank Plc provides commercial banking services. It offers personal, premier, business and corporate banking products and services to its customers. The banks services include current accounts, savings, investments, mortgages, loans, insurance, credit cards and online banking services. The company was founded on October 4, 1971 and is headquartered in London, the United Kingdom. | Major Banks | Chief Executive Officer | |
AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer | |
COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member | |
Brighton Biotech, Inc.
![]() Brighton Biotech, Inc. BiotechnologyHealth Technology Brighton Biotech, Inc. provides medical research services. It specializes in acquiring and developing pharmaceutical and biotechnology products intended for the treatment and prevention of serious unmet medical needs. The company was founded in 2010 and is headquartered in New York, NY. | Biotechnology | Corporate Officer/Principal | |
WAVE LIFE SCIENCES LTD. | Biotechnology | Director/Board Member | |
University of Virginia | College/University | Doctorate Degree | |
University of Oxford | College/University | Graduate Degree | |
The University of Sydney | College/University | Undergraduate Degree | |
Nabriva Therapeutics GmbH
![]() Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
SBI Japannext Co., Ltd.
![]() SBI Japannext Co., Ltd. Investment Banks/BrokersFinance SBI Japannext Co., Ltd. operates an online trading system. It creates a proprietary trading system venue to replicate the electronic connection networks in the United States serving as an after-hours market for online users. The company was founded on November 8, 2006 and is headquartered in Tokyo, Japan. | Investment Banks/Brokers | Director/Board Member | |
Barclays International
![]() Barclays International Major BanksFinance Part of Barclays PLC, Barclays International is a British company that provides banking services. The company is based in London, UK. The CEOs of the company are James Edward Staley, Alisa Copeman. | Major Banks | Chief Executive Officer | |
TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Perseus Holdings USA LLC
![]() Perseus Holdings USA LLC Electronics DistributorsDistribution Services Perseus Holdings USA LLC markets vaccine platform technology. The company is headquartered in Austin, TX. | Electronics Distributors | Director/Board Member | |
Exacis Biotherapeutics, Inc.
![]() Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Part of Eterna Therapeutics, Inc., Exacis Biotherapeutics, Inc. is a development stage immuno-oncology company based in Cambridge, MA. Exacis uses its proprietary-based technologies to engineer next generation off-the-shelf NK and T cell therapies aimed at liquid and solid tumors. Exacis has an exclusive license to the Factor Bioscience technology for engineered NK and T cell products derived from iPSCs for use in oncology and holds all development and commercial rights for these investigational candidates. Exacis' approach avoids the use of DNA and viruses and instead uses a proprietary-based technology to generate iPSCs and to edit their genome to create stealthed, performance-enhanced allogeneic NK and T cell products, termed ExANK™, Exacar-NK™, and Exacar-T™ cells. The company was founded in 2020 by Gregory Fiore, Matthew Angel, James Pan. Gregory Fiore has been the CEO since 2020. Exacis Biotherapeutics was acquired by Eterna Therapeutics, Inc. on May 02, 2023 for $49 million. | Medical/Nursing Services | Chairman | |
Wave Life Sciences USA, Inc.
![]() Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Electric Utilities | Director/Board Member | |
SB Investment Advisers (UK) Ltd.
![]() SB Investment Advisers (UK) Ltd. Investment ManagersFinance SB Investment Advisers (UK) Ltd. is a Private Equity firm, a subsidiary of SoftBank Group Corp. founded in 2016 by Masayoshi Son. SB Investment Advisers (UK) Ltd. is headquartered in London, UK. | Investment Managers | Private Equity Investor | |
Tremeau Pharmaceuticals, Inc.
![]() Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
Lumos Global Ltd.
![]() Lumos Global Ltd. Apparel/Footwear RetailRetail Trade Lumos Global Ltd. is an investment holding company. It operates through its subsidiaries, which engages in the retail of infant, toddler, children and maternity products. The company was founded on February 2, 2018 and is headquartered in Singapore. | Apparel/Footwear Retail | Director/Board Member | |
LNW Gaming, Inc.
![]() LNW Gaming, Inc. Packaged SoftwareTechnology Services LNW Gaming, Inc. develops and operates games cross-platform. The company is based in Las Vegas, NV. The CEO of the company is Matthew Wilson. | Packaged Software | Director/Board Member | |
NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
UNC School of Medicine | College/University | Corporate Officer/Principal | |
Pamlico BioPharma, Inc.
![]() Pamlico BioPharma, Inc. BiotechnologyHealth Technology Pamlico BioPharma, Inc. provides antibody therapeutics services. It develops fully-human monoclonal antibody (hmAb) therapeutics for the rapid diagnosis and treatment of infectious diseases and cancer. The firms lead program is focused on severe pneumonia caused by streptococcus pneumoniae (SPN), and is in preclinical IND-directed activities for a mAb cocktail and a companion point-of-care (POC) diagnostic against three serotypes that account for over 40% of SPN infections. The company was founded on 18 December, 2014 and is headquartered in Oklahoma, OK. | Biotechnology | Director/Board Member | |
BlackThorn Therapeutics, Inc.
![]() BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chairman | |
Citadel Asia Ltd.
![]() Citadel Asia Ltd. Investment ManagersFinance Citadel Asia Ltd. is the Hong Kong-based asset management subsidiary of Citadel Enterprise Americas LLC, which is ultimately owned by GFH HFEVA LLC, an investment company headquartered in the US. The firm was founded in 2005 and formerly known as Citadel (Hong Kong) Ltd. Citadel Asia offers multiple investment strategies for high net worth clients. | Investment Managers | President |
Statistik
International
Vereinigte Staaten | 27 |
Vereinigtes Königreich | 4 |
Kanada | 4 |
Japan | 3 |
Singapur | 2 |
Sektoral
Health Technology | 23 |
Finance | 7 |
Consumer Services | 6 |
Distribution Services | 3 |
Health Services | 3 |
Operativ
Director/Board Member | 29 |
Independent Dir/Board Member | 8 |
Chairman | 6 |
Chief Executive Officer | 6 |
President | 5 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Mark Corrigan | 29 |
Timothy Throsby | 10 |
Mark Edward Agne | 3 |
James D. Marks | 3 |
Nick Taylor | 1 |
- Börse
- Insiders
- Thomas Murtagh
- Unternehmensverbindungen